Home › SEC Filings › Current Report (8-K)
Current Report (8-K)
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| BWMN | DEFA14A, 8-K | bullish | 6/10 | Bowman Consulting Group announced the expiration of the 35-day go-shop period under its merger agreement with Bernhard C | Sep 14, 2026 |
| SMMT | 8-K | bullish | 7/10 | Summit Therapeutics announced via 8-K that its partner Akeso presented updated overall survival (OS) data from the Phase | Sep 14, 2026 |
| CLIR | 8-K | neutral | 2/10 | ClearSign Technologies filed an 8-K on September 14, 2026, solely to announce that it posted an investor presentation on | Sep 14, 2026 |
| BMNR | 8-K | neutral | 4/10 | Bitmine Immersion Technologies issued an 8-K with a press release updating its crypto holdings as of September 13, 2026. | Sep 14, 2026 |
| CMBMF | 8-K | bearish | 9/10 | Cambium Networks placed its indirect wholly-owned UK subsidiary, Cambium Networks Ltd (CNL), into administration (UK ins | Sep 14, 2026 |
| SMTK | 8-K | bullish | 6/10 | SmartKem, Inc. (SMTK) received formal notice from Nasdaq Staff on September 10, 2026, confirming that its common stock c | Sep 14, 2026 |
| PURR | 8-K | neutral | 2/10 | Hyperliquid Strategies amended its ChEF Purchase Agreement with Chardan Capital Markets, reducing the discount on VWAP p | Sep 14, 2026 |
| FVN | 8-K | neutral | 4/10 | Future Vision II Acquisition Corp. issued a $65,000 unsecured promissory note to its sponsor to fund a one-month extensi | Sep 14, 2026 |
| WDC | 8-K | neutral | 4/10 | Western Digital announced the redemption of all $109.5M of its 3.00% Convertible Senior Notes due 2028, with a redemptio | Sep 14, 2026 |
| PRDO | 8-K | bullish | 7/10 | Perdoceo Education Corporation (PRDO) has signed a definitive agreement to acquire 100% of South University for a total | Sep 14, 2026 |
| CGEM | 8-K | bullish | 7/10 | Cullinan Therapeutics announced positive Phase 3 REZILIENT3 trial results for zipalertinib plus chemotherapy in first-li | Sep 14, 2026 |
| SLNH | 8-K | bullish | 6/10 | Soluna announced that ERCOT has conditionally classified its 100 MW Project Dorothy campus as Base Load in Batch Zero, f | Sep 14, 2026 |
| VWAV | 8-K | neutral | 4/10 | VisionWave Holdings, a prepackaged software company with no oil & gas experience, received a prequalification letter fro | Sep 14, 2026 |
| TCBI | 8-K | neutral | 4/10 | Texas Capital Bancshares (TCBI) announced it will voluntarily delist its common and preferred stock from Nasdaq and tran | Sep 14, 2026 |
| NHP | 8-K | neutral | 2/10 | Director Edward M. Weil, Jr. resigned from the board of National Healthcare Properties, effective September 11, 2026. Th | Sep 14, 2026 |
| CRBP | 8-K | bullish | 7/10 | Corbus Pharmaceuticals announced positive topline data from its CANYON-1 Phase 1b trial of CRB-913, an oral CB1 inverse | Sep 14, 2026 |
| ARMP | 8-K | bullish | 7/10 | Armata Pharmaceuticals announced FDA Breakthrough Therapy designation for AP-SA02, its intravenous phage therapy for com | Sep 14, 2026 |
| AIRJW | 8-K | bullish | 7/10 | AirJoule Technologies Corp. acquired 100% of Bitsink LLC for $18M cash and 1,859,504 shares of AIRJ common stock (valued | Sep 14, 2026 |
| IMCR | 8-K | bullish | 6/10 | Immunocore announced it has achieved target enrollment of 540 patients in its Phase 3 TEBE-AM registrational trial evalu | Sep 14, 2026 |
| FVR | 8-K | neutral | 4/10 | FrontView REIT released an investor update deck ahead of real estate conferences, highlighting YTD 2026 acquisition acti | Sep 14, 2026 |
| QTTB | 8-K | neutral | 3/10 | Q32 Bio announced the appointment of Dr. José Trevejo as Chief Medical Officer and Dr. Ellie Hershberger as Chief Develo | Sep 14, 2026 |
| SLDP | 8-K | neutral | 3/10 | Solid Power, Inc. published an updated investor presentation on September 14, 2026, outlining its strategy for sulfide-b | Sep 14, 2026 |
| NPKI | 8-K | neutral | 2/10 | NPK International appointed James Barton as Executive Vice President, Commercial Growth & Operations, effective Septembe | Sep 14, 2026 |
| FLS | 8-K | neutral | 3/10 | Flowserve announced the resignation of CFO Amy Schwetz (effective Sept 30, 2026) to join another company, and the immedi | Sep 14, 2026 |
| AITX | 8-K | neutral | 4/10 | AITX announced that its subsidiary RAD's ROSA and RIO platforms are now live on the Immix monitoring platform following | Sep 14, 2026 |
| ORCL | 8-K | bullish | 5/10 | Larry Ellison, Oracle's Executive Chair and CTO, cancelled his 10b5-1 plan to sell Oracle stock. No shares were sold und | Sep 14, 2026 |
| WYFI | 8-K | neutral | 5/10 | WhiteFiber, Inc. filed an 8-K with an investor presentation highlighting strong business momentum: a 10-year, ~$865M anc | Sep 14, 2026 |
| EMCGF | 8-K | bearish | 7/10 | Embrace Change Acquisition Corp. (EMCG) reported that its merger agreement with Tianji Tire Global (Cayman) Limited was | Sep 14, 2026 |
| LPCN | 8-K | bullish | 6/10 | Lipocine initiated the BLOOM Phase 3 study of LPCN 1154 (oral brexanolone) for postpartum depression, with first partici | Sep 14, 2026 |
| CATX | 8-K | bullish | 5/10 | Perspective Therapeutics announced a clinical collaboration and supply agreement with Merck to evaluate its targeted alp | Sep 14, 2026 |